Teladoc Health (NYSE:TDOC) Price Target Cut to $9.00

Teladoc Health (NYSE:TDOC) had its target price cut by Stifel Nicolaus from $16.00 to $9.00 in a research report released on Thursday morning, Benzinga reports. They currently have a hold rating on the health services provider’s stock.

Several other research firms have also issued reports on TDOC. Evercore ISI lowered their target price on shares of Teladoc Health from $14.00 to $10.00 and set an in-line rating on the stock in a research note on Tuesday, July 9th. JPMorgan Chase & Co. cut their price target on Teladoc Health from $19.00 to $16.00 and set a neutral rating for the company in a report on Tuesday, May 21st. Canaccord Genuity Group reduced their price objective on Teladoc Health from $25.00 to $17.00 and set a buy rating on the stock in a research report on Thursday. Bank of America reduced their price objective on Teladoc Health from $16.50 to $13.50 and set a neutral rating on the stock in a research report on Tuesday, May 14th. Finally, Royal Bank of Canada reduced their price objective on Teladoc Health from $25.00 to $18.00 and set an outperform rating on the stock in a research report on Friday, April 26th. Fourteen analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Teladoc Health has a consensus rating of Hold and an average price target of $14.44.

Teladoc Health Stock Performance

NYSE:TDOC traded down $0.35 during mid-day trading on Thursday, hitting $7.60. The company’s stock had a trading volume of 8,597,062 shares, compared to its average volume of 5,484,255. Teladoc Health has a 1 year low of $7.31 and a 1 year high of $26.00. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The stock has a market cap of $1.29 billion, a price-to-earnings ratio of -5.64 and a beta of 0.93. The business’s fifty day moving average is $9.88 and its two-hundred day moving average is $13.61.

Insider Activity

In other Teladoc Health news, CEO Laizer Kornwasser sold 10,879 shares of the company’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $88,555.06. Following the completion of the sale, the chief executive officer now directly owns 99,929 shares of the company’s stock, valued at approximately $813,422.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, insider Vidya Raman-Tangella sold 3,857 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the transaction, the insider now directly owns 33,667 shares of the company’s stock, valued at approximately $274,049.38. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Laizer Kornwasser sold 10,879 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $88,555.06. Following the transaction, the chief executive officer now directly owns 99,929 shares of the company’s stock, valued at $813,422.06. The disclosure for this sale can be found here. In the last three months, insiders sold 36,177 shares of company stock valued at $347,447. Insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of TDOC. ICA Group Wealth Management LLC acquired a new stake in Teladoc Health during the 4th quarter valued at $28,000. Signaturefd LLC grew its stake in Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after buying an additional 1,715 shares during the period. International Assets Investment Management LLC purchased a new stake in Teladoc Health during the second quarter worth approximately $29,000. Hexagon Capital Partners LLC boosted its stake in shares of Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares during the period. Finally, RIA Advisory Group LLC purchased a new position in shares of Teladoc Health in the fourth quarter valued at $36,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.